| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 20 | 2023 | 3675 | 2.430 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 11 | 2022 | 528 | 2.120 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 2616 | 0.850 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2022 | 876 | 0.780 |
Why?
|
| Radiation, Ionizing | 2 | 2019 | 190 | 0.740 |
Why?
|
| Fibroblasts | 2 | 2022 | 1659 | 0.590 |
Why?
|
| RNA, Untranslated | 7 | 2012 | 242 | 0.550 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 326 | 0.540 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 4153 | 0.530 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 192 | 0.530 |
Why?
|
| Longevity | 2 | 2016 | 154 | 0.530 |
Why?
|
| Insulin-Like Growth Factor II | 5 | 2012 | 113 | 0.490 |
Why?
|
| Genomic Imprinting | 6 | 2012 | 200 | 0.470 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 614 | 0.470 |
Why?
|
| Mice | 28 | 2023 | 35697 | 0.470 |
Why?
|
| Hematopoiesis | 2 | 2016 | 604 | 0.430 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 3449 | 0.420 |
Why?
|
| Ubiquitin | 1 | 2014 | 331 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 2459 | 0.390 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1470 | 0.390 |
Why?
|
| DNA-Binding Proteins | 8 | 2006 | 5030 | 0.390 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 594 | 0.390 |
Why?
|
| Repressor Proteins | 6 | 2012 | 1715 | 0.380 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 255 | 0.370 |
Why?
|
| Protein Multimerization | 1 | 2011 | 232 | 0.360 |
Why?
|
| DNA Damage | 4 | 2014 | 1987 | 0.340 |
Why?
|
| Models, Animal | 1 | 2012 | 670 | 0.340 |
Why?
|
| Animals | 32 | 2023 | 62359 | 0.340 |
Why?
|
| Transcriptional Activation | 5 | 2023 | 1111 | 0.340 |
Why?
|
| Embryonic Development | 1 | 2011 | 313 | 0.320 |
Why?
|
| Gene Expression | 1 | 2017 | 3658 | 0.320 |
Why?
|
| Protein Binding | 5 | 2022 | 3497 | 0.320 |
Why?
|
| Radiation Tolerance | 4 | 2018 | 636 | 0.310 |
Why?
|
| Organ Specificity | 2 | 2023 | 741 | 0.310 |
Why?
|
| Li-Fraumeni Syndrome | 2 | 2023 | 167 | 0.300 |
Why?
|
| Ribonuclease III | 2 | 2019 | 188 | 0.300 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2019 | 263 | 0.280 |
Why?
|
| Mutation | 9 | 2022 | 15918 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2014 | 5451 | 0.260 |
Why?
|
| Cell Cycle Proteins | 3 | 2017 | 2122 | 0.250 |
Why?
|
| Carcinogenesis | 4 | 2022 | 1035 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1511 | 0.250 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 257 | 0.220 |
Why?
|
| Neoplasms, Experimental | 3 | 2018 | 787 | 0.220 |
Why?
|
| Protein Stability | 2 | 2014 | 378 | 0.210 |
Why?
|
| Mice, Transgenic | 7 | 2018 | 4249 | 0.210 |
Why?
|
| Mice, Knockout | 6 | 2019 | 5750 | 0.210 |
Why?
|
| Geminiviridae | 1 | 2001 | 1 | 0.200 |
Why?
|
| Plants, Medicinal | 1 | 2001 | 49 | 0.200 |
Why?
|
| Genotype | 3 | 2016 | 4266 | 0.190 |
Why?
|
| Osteosarcoma | 2 | 2022 | 948 | 0.190 |
Why?
|
| Fabaceae | 1 | 2001 | 31 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 3220 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2019 | 12134 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 133 | 0.190 |
Why?
|
| CCCTC-Binding Factor | 6 | 2012 | 35 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2018 | 2120 | 0.180 |
Why?
|
| Ubiquitination | 2 | 2014 | 579 | 0.180 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 82 | 0.160 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 7404 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2001 | 450 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 9053 | 0.160 |
Why?
|
| Models, Biological | 3 | 2019 | 3207 | 0.160 |
Why?
|
| E2F6 Transcription Factor | 1 | 2017 | 10 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 14818 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 149 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 184 | 0.140 |
Why?
|
| Cloning, Molecular | 4 | 2006 | 1436 | 0.140 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 237 | 0.140 |
Why?
|
| Trans-Activators | 2 | 2006 | 1631 | 0.140 |
Why?
|
| Homozygote | 1 | 2018 | 767 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2018 | 1193 | 0.130 |
Why?
|
| Hyperpigmentation | 1 | 2016 | 35 | 0.130 |
Why?
|
| Doxorubicin | 2 | 2014 | 3144 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 1372 | 0.130 |
Why?
|
| RNA, Long Noncoding | 7 | 2012 | 619 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 7121 | 0.130 |
Why?
|
| Ultraviolet Rays | 2 | 2017 | 587 | 0.120 |
Why?
|
| Apoptosis | 4 | 2019 | 7783 | 0.120 |
Why?
|
| Lymphoma | 2 | 2017 | 1524 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2017 | 362 | 0.120 |
Why?
|
| ras Proteins | 1 | 2019 | 804 | 0.120 |
Why?
|
| Melanocytes | 1 | 2016 | 241 | 0.120 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2014 | 19 | 0.120 |
Why?
|
| Chromatin | 3 | 2012 | 1044 | 0.120 |
Why?
|
| Leupeptins | 1 | 2014 | 71 | 0.120 |
Why?
|
| Cycloheximide | 1 | 2014 | 111 | 0.120 |
Why?
|
| Skin | 2 | 2017 | 1281 | 0.110 |
Why?
|
| Dactinomycin | 1 | 2014 | 163 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2018 | 875 | 0.110 |
Why?
|
| Protein Denaturation | 1 | 2013 | 72 | 0.110 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 191 | 0.110 |
Why?
|
| Aging | 2 | 2018 | 1555 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2014 | 247 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 1287 | 0.100 |
Why?
|
| Proteolysis | 1 | 2014 | 377 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 807 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 654 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 4651 | 0.100 |
Why?
|
| Cesium Radioisotopes | 1 | 2011 | 38 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2011 | 453 | 0.090 |
Why?
|
| Point Mutation | 1 | 2014 | 788 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 653 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2014 | 492 | 0.090 |
Why?
|
| DNA Primers | 2 | 2011 | 1504 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 2033 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5740 | 0.080 |
Why?
|
| E2F5 Transcription Factor | 2 | 1999 | 8 | 0.080 |
Why?
|
| Transcription Factor DP1 | 2 | 1999 | 59 | 0.080 |
Why?
|
| E2F4 Transcription Factor | 2 | 1999 | 30 | 0.080 |
Why?
|
| Learning | 1 | 2012 | 434 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 554 | 0.080 |
Why?
|
| Alleles | 4 | 2018 | 2594 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2002 | 823 | 0.080 |
Why?
|
| DNA Methylation | 5 | 2012 | 2761 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 3621 | 0.080 |
Why?
|
| Phenotype | 2 | 2017 | 6493 | 0.080 |
Why?
|
| Humans | 18 | 2019 | 271550 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 5771 | 0.070 |
Why?
|
| Bone Neoplasms | 2 | 2022 | 2670 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6264 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2019 | 4976 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1899 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2012 | 2034 | 0.070 |
Why?
|
| Sarcoma | 1 | 2017 | 1840 | 0.070 |
Why?
|
| Male | 9 | 2018 | 128724 | 0.060 |
Why?
|
| Chromosomes | 1 | 2006 | 324 | 0.060 |
Why?
|
| Female | 11 | 2018 | 149106 | 0.060 |
Why?
|
| Biomarkers | 1 | 2017 | 5086 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2634 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2004 | 9 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 6706 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2002 | 136 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 21 | 0.060 |
Why?
|
| Methylation | 1 | 2004 | 625 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2006 | 1445 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2163 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 58 | 0.050 |
Why?
|
| CpG Islands | 1 | 2004 | 662 | 0.050 |
Why?
|
| Binding Sites | 4 | 2012 | 2260 | 0.050 |
Why?
|
| Leukemia | 1 | 2010 | 1721 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 5606 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2001 | 185 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 4894 | 0.050 |
Why?
|
| Cell Death | 1 | 2023 | 688 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5252 | 0.050 |
Why?
|
| Protein Folding | 1 | 2001 | 298 | 0.040 |
Why?
|
| Chloroplasts | 1 | 2000 | 12 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 57 | 0.040 |
Why?
|
| E2F2 Transcription Factor | 1 | 1999 | 27 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 1 | 1999 | 23 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 138 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 1999 | 175 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 592 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 15903 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2002 | 827 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 1999 | 200 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 4061 | 0.040 |
Why?
|
| Histone Chaperones | 1 | 2018 | 32 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2001 | 1258 | 0.040 |
Why?
|
| X-linked Nuclear Protein | 1 | 2018 | 54 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1998 | 80 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2018 | 120 | 0.040 |
Why?
|
| Base Sequence | 2 | 2001 | 5453 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 357 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 143 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 543 | 0.040 |
Why?
|
| Liver | 3 | 2014 | 3086 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1998 | 732 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 567 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 268 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 203 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 660 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 327 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 281 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2017 | 244 | 0.030 |
Why?
|
| Transfection | 2 | 2002 | 3130 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2000 | 555 | 0.030 |
Why?
|
| Carcinogens | 1 | 2017 | 392 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 16221 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 878 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 3038 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 5762 | 0.030 |
Why?
|
| Disease Progression | 2 | 2019 | 6857 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 624 | 0.030 |
Why?
|
| Histones | 2 | 2018 | 1513 | 0.030 |
Why?
|
| Transgenes | 1 | 2017 | 577 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 886 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 6436 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1463 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1360 | 0.030 |
Why?
|
| Response Elements | 1 | 2014 | 193 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1094 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 1309 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 3496 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 654 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 837 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1590 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2012 | 101 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2012 | 61 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 2199 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 145 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2462 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 253 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 4582 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 168 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 73451 | 0.020 |
Why?
|
| Plicamycin | 1 | 2010 | 29 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 507 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 537 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 982 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 90422 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 781 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2010 | 193 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 2482 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 488 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 507 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 1953 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 742 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 5315 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 773 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1389 | 0.020 |
Why?
|
| Actins | 1 | 2010 | 613 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 1248 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 1686 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 3610 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2096 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2010 | 1145 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 307 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10258 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 2438 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 282 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2004 | 3347 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5407 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 2825 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 1389 | 0.010 |
Why?
|
| Choriocarcinoma | 1 | 2002 | 49 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 810 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 146 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 105 | 0.010 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 77 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 223 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 166 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2002 | 455 | 0.010 |
Why?
|
| Light | 1 | 2000 | 281 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 460 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 632 | 0.010 |
Why?
|
| Temperature | 1 | 2000 | 539 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 944 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 13077 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 493 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 2002 | 579 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 1032 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2002 | 876 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 1589 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 22524 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 3055 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 33870 | 0.010 |
Why?
|
| Pregnancy | 1 | 2002 | 8110 | 0.000 |
Why?
|